Daclizumab Subcutaneous and Topiramate
Determining the interaction of Daclizumab Subcutaneous and Topiramate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: topiramate
Brand name: Qudexy XR Sprinkle, Topamax, Topamax Sprinkle, Trokendi XR, Topiragen, Qudexy XR
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Topiramate Capsules
- Daclizumab Subcutaneous-Topiramate ER Capsules
- Daclizumab Subcutaneous-Topiramate Extended-Release Capsules
- Daclizumab Subcutaneous-Topiramate Extended-Release Sprinkle Capsules
- Daclizumab Subcutaneous-Topiramate Sprinkle Capsules
- Daclizumab Subcutaneous-Topiramate Tablets
- Topiramate-Dacogen
- Topiramate-Dacomitinib
- Topiramate-Dactinomycin
- Topiramate-Dactinomycin Injection
- Topiramate-Dactinomycin Intravenous
- Topiramate-Daklinza